UCLA Center for IBD - Aria Zand presenting his research: DOP026. Work related problems and impaired productivity in patients with inflammatory bowel diseases (IBD) https://www.ecco-ibd.eu/publications/congress-abstract-s/abstracts-2014/item/dop026-work ...
![Peter Bossuyt, ECCO-IBD 2022: Risankizumab in Crohn's Disease - Post Hoc Analysis of ADVANCE, MOTIVATE, and FORTIFY - touchIMMUNOLOGY Peter Bossuyt, ECCO-IBD 2022: Risankizumab in Crohn's Disease - Post Hoc Analysis of ADVANCE, MOTIVATE, and FORTIFY - touchIMMUNOLOGY](https://embed-ssl.wistia.com/deliveries/609958c243bd916768548d33987b8700.webp?image_crop_resized=960x540)
Peter Bossuyt, ECCO-IBD 2022: Risankizumab in Crohn's Disease - Post Hoc Analysis of ADVANCE, MOTIVATE, and FORTIFY - touchIMMUNOLOGY
![Journal of Crohn's and Colitis | Abstracts of the 8th Congress of ECCO – the European Crohn's and Colitis Organisation | ScienceDirect.com by Elsevier Journal of Crohn's and Colitis | Abstracts of the 8th Congress of ECCO – the European Crohn's and Colitis Organisation | ScienceDirect.com by Elsevier](https://ars.els-cdn.com/content/image/1-s2.0-S1873994613X00030-cov200h.gif)
Journal of Crohn's and Colitis | Abstracts of the 8th Congress of ECCO – the European Crohn's and Colitis Organisation | ScienceDirect.com by Elsevier
![Review of the 17th Congress of the European Crohn's and Colitis Organisation (ECCO) - European Medical Journal Review of the 17th Congress of the European Crohn's and Colitis Organisation (ECCO) - European Medical Journal](https://www.emjreviews.com/wp-content/uploads/2022/03/Feature-Image-Gastroenterology-11-Supplement-1-ECCO.jpg)
Review of the 17th Congress of the European Crohn's and Colitis Organisation (ECCO) - European Medical Journal
![PDF) 4th Congress of ECCO Inflammatory Bowel Diseases Impact of antiTNF treatment on Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: real world data in Germany PDF) 4th Congress of ECCO Inflammatory Bowel Diseases Impact of antiTNF treatment on Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: real world data in Germany](https://i1.rgstatic.net/publication/337008399_4th_Congress_of_ECCO_-_Inflammatory_Bowel_Diseases_Impact_of_anti-TNF_treatment_on_Extra-intestinal_Manifestations_in_Patients_with_Inflammatory_Bowel_Disease_real_world_data_in_Germany/links/5dc01db392851c818028b1a3/largepreview.png)
PDF) 4th Congress of ECCO Inflammatory Bowel Diseases Impact of antiTNF treatment on Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: real world data in Germany
![JCM | Free Full-Text | An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis JCM | Free Full-Text | An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis](https://pub.mdpi-res.com/jcm/jcm-11-02302/article_deploy/html/images/jcm-11-02302-g001.png?1650457533)
JCM | Free Full-Text | An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis
![Journal of Crohn's and Colitis | Includes Abstracts of the 4th Congress of ECCO | ScienceDirect.com by Elsevier Journal of Crohn's and Colitis | Includes Abstracts of the 4th Congress of ECCO | ScienceDirect.com by Elsevier](https://ars.els-cdn.com/content/image/1-s2.0-S1873994608X00078-cov200h.gif)